News & analysis on the clinical development and manufacture of large molecule drugs
By Natalie Morrison
- Last updated on
Greeley comes to the Philadelphia-based pharmaceutical compliance consulting firm with a solid track record in areas such as strategic planning, business development, and P&L management.
In his new role, Greeley will oversee the manufacturing practice group, helping clients meet cGMP (current good manufacturing practice) in a number of fields, including document control systems, inspection readiness, internal system audits, development of Key Performance Indicators, and training.
Of his new position he said: “I am elated to bring my industry expertise to CIS in leading the Manufacturing Practice Group and expand the services we currently offer.”